Valganciclovir: Difference between revisions
From IDWiki
(Created page with "* Valine ester of ganciclovir with much higher oral bioavailability (70%)") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Background == |
|||
* Valine ester of [[ganciclovir]] with much higher oral bioavailability (70%) |
* Valine ester of [[ganciclovir]] with much higher oral bioavailability (70%) |
||
* Indications: {{#ask: [[Is treated by::valganciclovir]] | default=none}} |
|||
== Dosing == |
|||
* [[CMV after solid organ transplantation|CMV prophylaxis in solid organ transplant]]: 900 mg p.o. daily |
|||
* Mild-to-moderate [[CMV after solid organ transplantation|CMV disease in solid organ transplant]]: 900 mg p.o. twice daily |
|||
* [[CMV after hematopoietic stem cell transplantation|CMV viremia in hematopoietic stem cell transplant]]: 900 mg p.o. twice daily for 7 to 14 days followed by once daily until negative PCR |
|||
=== Renal Dosing === |
|||
{| class="wikitable" |
|||
!CrCl |
|||
!Induction or Treatment |
|||
!Maintenance or Prophylaxis |
|||
|- |
|||
|≥60 |
|||
|900 mg twice daily |
|||
|900 mg once daily |
|||
|- |
|||
|40 to 59 |
|||
|450 mg twice daily |
|||
|450 mg once daily |
|||
|- |
|||
|25 to 39 |
|||
|450 mg once daily |
|||
|450 mg every 2 days |
|||
|- |
|||
|10 to 24 |
|||
|450 mg every 2 days |
|||
|450 mg twice weekly |
|||
|- |
|||
|<10 |
|||
|Not recommended; may consider using oral solution 200 mg 3 times weekly |
|||
|Not recommended; may consider using oral solution 100 mg 3 times weekly |
|||
|} |
|||
== Safety == |
|||
=== Adverse Effects === |
|||
* Long list |
|||
* Anemia, thrombocytopenia, and neutropenia |
|||
[[Category:Antivirals]] |
|||
Latest revision as of 21:59, 22 February 2024
Background
- Valine ester of ganciclovir with much higher oral bioavailability (70%)
- Indications: CMV after hematopoietic stem cell transplantation, CMV after solid organ transplantation, Congenital CMV, Cytomegalovirus, Herpesviridae
Dosing
- CMV prophylaxis in solid organ transplant: 900 mg p.o. daily
- Mild-to-moderate CMV disease in solid organ transplant: 900 mg p.o. twice daily
- CMV viremia in hematopoietic stem cell transplant: 900 mg p.o. twice daily for 7 to 14 days followed by once daily until negative PCR
Renal Dosing
| CrCl | Induction or Treatment | Maintenance or Prophylaxis |
|---|---|---|
| ≥60 | 900 mg twice daily | 900 mg once daily |
| 40 to 59 | 450 mg twice daily | 450 mg once daily |
| 25 to 39 | 450 mg once daily | 450 mg every 2 days |
| 10 to 24 | 450 mg every 2 days | 450 mg twice weekly |
| <10 | Not recommended; may consider using oral solution 200 mg 3 times weekly | Not recommended; may consider using oral solution 100 mg 3 times weekly |
Safety
Adverse Effects
- Long list
- Anemia, thrombocytopenia, and neutropenia
